A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809
Conditions: Osteoarthritis; Rheumatoid Arthritis; Back Pain; Acute Upper Respiratory Tract Infection Interventions: Drug: DW1809; Drug: DW1809-1 Sponsor: Daewon Pharmaceutical Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials